Placental Insufficiency Clinical Trial
Official title:
Reference Ranges for Placental Perfusion Using Magnetic Resonance Imaging (MRI)PLACENTIMAGE
To evaluate the feasibility of functional MRI method developed in an animal model and to construct normal reference ranges for in vivo placental perfusion using functional MRI. This will be based on imaging studies in patients undergoing termination of pregnancy (TOP) at 16 to 32 weeks' for fetal reason in a tertiary referral center.
Objective:
To evaluate the feasibility of functional MRI method developed in an animal model and to
construct normal reference ranges for in vivo placental perfusion using functional MRI. This
will be based on imaging studies in patients undergoing termination of pregnancy (TOP) at 16
to 32 weeks' for fetal reason in a tertiary referral center.
Method:
All patients undergoing TOP at 16 to 32 weeks will be offered to participate in this study.
120 patients will be included. 15 per group of weeks of gestation: 16+0-17+6 SA, 18+0-19+6
SA, 20+0-21+6 SA, 22+0-23+6 SA, 24+0-25+6 SA, 26+0-27+6 SA, 28+0-29+6 SA, 30+0-31+6 WG.
MRI will be performed in the same hospital, during hospital stay, within 45 minutes.
Two MRI sequences will be used to measure placental perfusion:
- dynamic sequences using Gd contrast agent.
- " spin tagging ", which do not need any contrast agent. Perfusion will be modelled using
compartmental analysis. Reference ranges will be build up by statistical modelling.
Gadolinium assays will be performed on amniotic fluid and placental tissue following
TOP.
Duration of inclusion: 24 months.
Duration of patient participation: 45 minutes.
Expected results:
- Feasibility in routine practice.
- Reference ranges for placental perfusion.
- Comparison between the two measurements methods.
Adverse outcome measure:
Nausea, vomiting, lack of comfort and other adverse outcome.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01616615 -
Aspirin for the Enhancement of Trophoblastic Invasion in Women With Abnormal Uterine Artery Doppler at 11-14 Weeks of Gestation
|
Phase 2 | |
| Completed |
NCT01352234 -
Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia
|
Phase 4 | |
| Recruiting |
NCT03100084 -
PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome
|
||
| Completed |
NCT03731546 -
Effect of Delayed Cord Clamping in Preterm Neonates With Placental Insufficiency
|
N/A | |
| Completed |
NCT03528967 -
Enoxaparin in the Prevention of Placental Insufficiency in Pregnant Women
|
Phase 4 | |
| Recruiting |
NCT06039319 -
Acute Effects of Maternal Exercise and the Growth Restricted Pregnancy
|
||
| Completed |
NCT00465634 -
Doppler and Biological Second Trimester Placental Insufficiency Screening
|
N/A | |
| Not yet recruiting |
NCT06339606 -
Pregnancy Repository
|
||
| Completed |
NCT01388322 -
Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy
|
Phase 3 | |
| Recruiting |
NCT05423665 -
Speckle Tracking Echocardiography as a Tool for Early Diagnosis of Impaired Fetal Growth Twin Pregnancies
|
||
| Completed |
NCT01736826 -
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
|
||
| Completed |
NCT00930397 -
Observational Study in UTERO - Placental 3D Doppler Examination: Interest for Pre-eclampsia Screening During Pregnancy
|
||
| Enrolling by invitation |
NCT05381272 -
Impact of Early and Severe Fetal Growth Restriction on Neurodevelopmental Outcomes in Preterm Infants
|
||
| Completed |
NCT02971566 -
Splanchnic Oxygenation Response to Enteral Feeds in Preterm Infants With Abnormal Antenatal Doppler.
|
N/A | |
| Completed |
NCT03731611 -
Impact of Umbilical Cord Milking in Preterm Neonates With Placental Insufficiency
|
N/A |